tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
CAMP4 Therapeutics Announces $28 Million Common Stock Offering
PremiumCompany AnnouncementsCAMP4 Therapeutics Announces $28 Million Common Stock Offering
3M ago
External Validation and Strengthened Balance Sheet Underpin Buy Rating on CAMP4 Therapeutics
Premium
Ratings
External Validation and Strengthened Balance Sheet Underpin Buy Rating on CAMP4 Therapeutics
3M ago
CAMP4, GSK form RNA therapeutics collaboration agreement
Premium
Company Announcements
CAMP4, GSK form RNA therapeutics collaboration agreement
3M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
3M ago
CAMP Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
CAMP Earnings this Week: How Will it Perform?
4M ago
Strategic Focus and Financial Strength Drive Buy Rating for CAMP4 Therapeutics
Premium
Ratings
Strategic Focus and Financial Strength Drive Buy Rating for CAMP4 Therapeutics
4M ago
Promising Prospects for CAMP4 Therapeutics: Buy Rating Affirmed Amid Advancements in CMP-SYNGAP-01 Program and Strong Investor Confidence
PremiumRatingsPromising Prospects for CAMP4 Therapeutics: Buy Rating Affirmed Amid Advancements in CMP-SYNGAP-01 Program and Strong Investor Confidence
6M ago
Apple initiated, Hershey upgraded: Wall Street’s top analyst calls
Premium
The Fly
Apple initiated, Hershey upgraded: Wall Street’s top analyst calls
6M ago
Camp4 Therapeutics downgraded to Neutral from Overweight at JPMorgan
Premium
The Fly
Camp4 Therapeutics downgraded to Neutral from Overweight at JPMorgan
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100